AMIX | Autonomix Medical, Inc. Common Stock Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	3.00 - 3.60
52 Week Range	2.8800 - 152.00
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	286,624
Average Volume	545,565
Shares Outstanding	1,767,649
Market Cap	6,363,536
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2024-01-29

Valuation
Profitability
Growth
Health
P/E Ratio	-0.18
Forward P/E Ratio	N/A
EPS	-19.74
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	5
Country	USA
Website	AMIX

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

*Chart delayed

Analyzing fundamentals for AMIX we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see AMIX Fundamentals page.

Watching at AMIX technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on AMIX Technicals page.